Aethlon Medical Starts First Trial of Device Against HIV

Xconomy San Diego — 

San Diego-based Aethlon Medical (OTCBB: AETH) said today it has begun the first clinical trial of a medical device to treat HIV. The device, called Aethlon Hemopurifier, filters viruses and immune-suppressing proteins, in order to help the immune system fight HIV. The trial, of six patients, is being conducted in India.